Senores Pharma Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

The Senores Pharma stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Senores Pharma share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Senores Pharma stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Senores Pharma Stock in 2026

Analyst consensus on the Senores Pharma stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage	Rating	Senores Pharma Stock Prediction (Rs)	Updated
JM Financial	Buy	Rs 1600	2026
ICICI Securities	Neutral	Rs 1475	2026
Analyst Consensus	—	Rs 1538	2026

The analyst target range for Senores Pharma reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Senores Pharma stock forecast from the current price of Rs 1,347.1 may or may not be realised by end of 2026.

Senores Pharma Company Overview

Senores Pharmaceuticals is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Senores Pharma stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.

Metric	Value
NSE Ticker	SENORES
Sector	Pharmaceuticals and Healthcare
CMP	Rs 1,347.1 (2026)
52 Week High	—
52 Week Low	—
Market Cap	—
P/E Ratio	—
Senores Pharma Stock Prediction Consensus (12M)	Rs 1538

Senores Pharma Stock Prediction by Time Horizon

Analysts split the Senores Pharma share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Senores Pharma Stock Prediction

The near-term Senores Pharma stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,347.1 are being watched closely. A short-term Senores Pharma share price prediction carries the most uncertainty of any time horizon.

12-Month Senores Pharma Stock Prediction

JM Financial targets Rs 1600 (Buy) and ICICI Securities targets Rs 1475 (Neutral). Most desks refresh their Senores Pharma stock forecast within two to four weeks of each quarterly earnings print. The Senores Pharma share price prediction should be verified against the most recent analyst reports.

Long-Term Senores Pharma Stock Prediction

The long-term outlook for Senores Pharma is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.

Senores Pharma Stock Forecast: Key Factors

The following four factors appear consistently in analyst research on Senores Pharma and are the primary inputs into the bull and bear case scenarios.

US Generic Revenue

US generics revenue is the most watched metric in the Senores Pharma stock forecast. USFDA approval timelines and price erosion rates directly affect the Senores Pharma share price prediction from most research desks.

Domestic Formulations Growth

Domestic formulation growth provides a stable base that supports the Senores Pharma stock prediction even when export growth faces headwinds.

R&D Pipeline

The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Senores Pharma share price prediction. New product approvals are cited as catalysts for the Senores Pharma stock prediction.

EBITDA Margin

Sustained EBITDA margin expansion is typically the basis for the bullish Senores Pharma stock forecast. Margin recovery strengthens the Senores Pharma share price prediction from most research desks.

Senores Pharma Stock Prediction: Bull and Bear Scenarios

Scenario	Senores Pharma Stock Prediction	Key Conditions
Bull Case	Rs 1600	Strong execution, margin improvement, favourable macro and sector re-rating
Base Case	Rs 1538	Steady performance, gradual recovery, margins hold, growth on track
Bear Case	Rs 1,307	Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Senores Pharma stock forecast of Rs 1600 assumes most positive variables converge. The base case of Rs 1538 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Senores Pharma Stock Story

Analyst reviews of the Senores Pharma share price prediction highlight the company’s core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Senores Pharma is built on real business strengths set against real risks.

Key Risks to the Senores Pharma Stock Prediction

USFDA Regulatory Risk

Import alerts and warning letters from the USFDA are the most significant risks to the Senores Pharma stock prediction. A facility closure would force an immediate sharp revision to the Senores Pharma share price prediction.

Price Erosion in the US

Pricing pressure in US generics compresses the revenue per product and affects the Senores Pharma stock forecast. Aggressive price erosion pushes the Senores Pharma share price prediction toward the bear case.

R&D Execution Risk

Delays in clinical trials or approval failures affect the Senores Pharma stock prediction. The Senores Pharma share price prediction is particularly sensitive to key pipeline asset announcements.

Currency Risk

A strengthening rupee against the dollar reduces export realisation and affects the Senores Pharma stock forecast. Currency risk is embedded in conservative Senores Pharma share price prediction models.

How to Monitor the Senores Pharma Stock Forecast

Track the Senores Pharma share price prediction consensus quarterly. After every earnings release, most brokerages revise their Senores Pharma stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Senores Pharma is improving or deteriorating.

Compare the current price of Rs 1,347.1 with the analyst target range of Rs 1600 to Rs 1475. A wide target band reflects genuine uncertainty on Senores Pharma, so position size should reflect that range rather than the midpoint alone.

Review the Senores Pharma share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Senores Pharma Fundamentals on the Univest Screener

Conclusion

The Senores Pharma stock prediction for 2026 reflects the analyst community’s assessment of Senores Pharmaceuticals’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 1600 while ICICI Securities has a Neutral rating with a target of Rs 1475, giving an analyst consensus of Rs 1538.

The Senores Pharma stock forecast is set against near-term risks that make the Senores Pharma share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Senores Pharma share price target changes over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Senores Pharma in real time.

Frequently Asked Questions on Senores Pharma Stock Prediction 2026

What is the Senores Pharma stock prediction for 2026?

Ans. The Senores Pharma stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 1538. All estimates may or may not be achieved.

Is the Senores Pharma stock prediction bullish or bearish?

Ans. JM Financial has a Buy rating with target Rs 1600. ICICI Securities has a Neutral rating with target Rs 1475. The Senores Pharma stock forecast reflects genuine analyst diversity of opinion.

What is the Senores Pharma share price prediction based on fundamentals?

Ans. The Senores Pharma share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking Senores Pharma closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Senores Pharma stock prediction?

Ans. The long-term outlook assumes Senores Pharma sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1538 is the nearest reliable anchor point.

What are the key risks to the Senores Pharma stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Senores Pharma should be read alongside its risk assumptions.

What does the Senores Pharma stock forecast say for 2026?

Ans. JM Financial: Buy target Rs 1600. ICICI Securities: Neutral target Rs 1475. These Senores Pharma share price prediction estimates may or may not prove accurate.

Where can I track the latest Senores Pharma stock prediction?

Ans. Track the latest analyst targets and price movements for Senores Pharma on the NSE and BSE websites and on the Univest app and screener for live data.